Jefferies and Citigroup reaffirmed buy ratings on ArcelorMittal shares, while Benzinga and MarketBeat tracked company developments.
2 reports, 1 independent
Updated Sep 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies and Citigroup reaffirmed buy ratings on ArcelorMittal shares, while Benzinga and MarketBeat tracked company developments.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ArcelorMittal
multinational steel manufacturing corporation
-
Jefferies Financial Group
American financial services company
Related events
- MarketBeat reported consensus rating for Hikma Pharmaceuticals, while Jefferies increased its target price and gave a buy rating. Berenberg Bank reaffirmed its buy rating, and Citigroup restated a buy rating.
- MarketBeat reported the stock's average rating as Benchmark and Jefferies reiterated buy ratings for Bright Minds Biosciences Inc.
- Jefferies, Citigroup, and Leerink Partners issued rating updates and price targets for Phathom Pharmaceuticals.
- Jefferies Financial Group reiterated a buy rating on Constellation Software stock.
- BHC received a 'hold' rating from Jefferies, while MarketBeat provided consensus data and the board initiated a stock buyback plan.